<H1>Chapter DOI: 10.1208/aapsj070115<br/>Cited-By Count: 17</H1><table border="1" width="30%"><tr><td>Total References</td><td>30</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>28</td></tr><tr><td>BibStructured Count</td><td width="10%">28</td></tr><tr><td>BibUnstructured Count</td><td width="10%">2</td></tr><tr><td>DOI already available in SpringerLink</td><td>21</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibChapter</td><td>Burstein S. Therapeutic Potential of Ajulemic Acid (CT-3): In: Grontenhermen F, Russo E, eds.<Emphasis Type="Italic">Cannabis and Cannabinoids</Emphasis>. Binghamton, NY: Haworth Press Inc; 2002;381&#8211;388.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.4324/9780203479506>10.4324/9780203479506</a></td><td><b>CrossRef-Web</b></td>
<td>Year, BookTitle</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Burstein SH. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.<Emphasis Type="Italic">Curr Pharm Des.</Emphasis> 2000;6:1339&#8211;1345.</td><td><a href=http://dx.doi.org/10.2174/1381612003399473>10.2174/1381612003399473</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Burstein SH. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential.<Emphasis Type="Italic">Pharmacol Ther.</Emphasis> 1999;82:87&#8211;96.</td><td><a href=http://dx.doi.org/10.1016/S0163-7258(98)00069-2>10.1016/S0163-7258(98)00069-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Burstein SH, Karst M, Schneider U, Zurier RB. Ajulemic acid: a novel cannabinoid produces analgesia without a &#8220;high&#8221;.<Emphasis Type="Italic">Life Sci.</Emphasis> 2004;75:1513&#8211;1522.</td><td><a href=http://dx.doi.org/10.1016/j.lfs.2004.04.010>10.1016/j.lfs.2004.04.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Burstein S, Hunter SA, Latham V, Renzulli L. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.<Emphasis Type="Italic">Experientia.</Emphasis> 1987;43:402&#8211;403.</td><td><a href=http://dx.doi.org/10.1007/BF01940427>10.1007/BF01940427</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Burstein S, Shoupe TS. Metabolic pathways for the transformation of delta 1-tetrahydrocannabinol in mouse hepatic microsomes.<Emphasis Type="Italic">Drug Metab Dispos.</Emphasis> 1981;9:94&#8211;96.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Burstein S, Rosenfeld J, Wittstruck T. Isolation and characterization of two major urinary metabolites of 1-tetrahydrocannabinol.<Emphasis Type="Italic">Science.</Emphasis> 1972;176:422&#8211;423.</td><td><a href=http://dx.doi.org/10.1126/science.176.4033.422>10.1126/science.176.4033.422</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Burstein SH, Kupfer D. Hydroxylation of trans-1-tetrahydrocannabinol by a hepatic microsomal monooxygenase.<Emphasis Type="Italic">Chem Biol Interact.</Emphasis> 1971;3:316.</td><td><a href=http://dx.doi.org/10.1016/0009-2797(71)90078-0>10.1016/0009-2797(71)90078-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Burstein SH, Menezes F, Williamson E, Mechoulam R. Metabolism of delta 1(6)-tetrahydro-cannabinol, an active marihuana constituent.<Emphasis Type="Italic">Nature</Emphasis>, 1970;225:87&#8211;88.</td><td><a href=http://dx.doi.org/10.1038/225087a0>10.1038/225087a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibChapter</td><td>Perez-Reyes M. Pharmacodynamics of certain drugs of abuse. In: Barnett G, Chang CN, eds.<Emphasis Type="Italic">Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs</Emphasis>. Foster City, CA: Biomedical Publishers; 1985;287&#8211;310.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Burstein S, Hunter SA, Latham V, Renzulli L. Prostaglandins and cannabis-XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 1986;35:2553&#8211;2558.</td><td><a href=http://dx.doi.org/10.1016/0006-2952(86)90053-5>10.1016/0006-2952(86)90053-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Burstein SH, Hull K, Hunter SA, Latham V. Cannabinoids and pain responses: a possible role for prostaglandins.<Emphasis Type="Italic">FASEB J.</Emphasis> 1988;2:3022&#8211;3026.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Burstein SH, Audette CA, Doyle SA, Hull K, Hunter SA, Latham V. Antagonism to the actions of platelet activating factor by a non-psychoactive cannabinoid.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1989;251:531&#8211;535.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Doyle SA, Burstein SH, Dewey WL, Welch SP. Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.<Emphasis Type="Italic">Agents Actions.</Emphasis> 1990;31:157&#8211;163.</td><td><a href=http://dx.doi.org/10.1007/BF02003237>10.1007/BF02003237</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Burstein SH, Audette CA, Breuer A, et al. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1992;35: 3135&#8211;3141.</td><td><a href=http://dx.doi.org/10.1021/jm00095a007>10.1021/jm00095a007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.<Emphasis Type="Italic">JAMA.</Emphasis> 2003;290: 1757&#8211;1762.</td><td><a href=http://dx.doi.org/10.1001/jama.290.13.1757>10.1001/jama.290.13.1757</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Rhee MH, Vogel Z, Barg J, et al. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1997;40:3228&#8211;3233.</td><td><a href=http://dx.doi.org/10.1021/jm970126f>10.1021/jm970126f</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Compton DR, Rice KC, De Costa BR, et al. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;265:218&#8211;226.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Recht LD, Salmonsen R, Rosetti R, et al. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2001;62:755&#8211;763.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(01)00700-6>10.1016/S0006-2952(01)00700-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Hunter SA, Burstein SH. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis.<Emphasis Type="Italic">Life Sci.</Emphasis> 1997;60:1563&#8211;1573.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(97)00122-7>10.1016/S0024-3205(97)00122-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Stebulis</span> <span style='background:#DDDDDD'>JA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Burstein</span> <span style='background:#DDDDDD'>SH</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Torres</span> <span style='background:#DDDDDD'>R</span></span>, et al.</aug> Ajulemic Acid, an antiinflammatory nonpsychoactive cannabinoid acid, modulates activation of human synovial cells. Paper presented at: <span style='background:#66FF66'>2004</span> <span style='background:#FFD9B3'>Symposium on the Cannabinoids. June 20, 2004; Paestum</span>, <span style='background:#C0FFC0'>Italy</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SA, Burstein SH. Dimethylheptyl-THC-11-oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 1998;41:163&#8211;170.</td><td><a href=http://dx.doi.org/10.1002/1529-0131(199801)41:1&lt;163::AID-ART20&gt;3.0.CO;2-9>10.1002/1529-0131(199801)41:1&lt;163::AID-ART20&gt;3.0.CO;2-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Dajani EZ, Larsen KR, Taylor J, et al. 1&#8242;,1&#8242;-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;291:31&#8211;38.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Burstein SH, Friderichs E, Kogel B, Schneider J, Selve N. Analgesic effects of 1&#8242;,1&#8242; dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice.<Emphasis Type="Italic">Life Sci.</Emphasis> 1998;63:161&#8211;168.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(98)00256-2>10.1016/S0024-3205(98)00256-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Bidinger B, Torres R, Rossetti RG, et al. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes.<Emphasis Type="Italic">Clin Immunol.</Emphasis> 2003;108:95&#8211;102.</td><td><a href=http://dx.doi.org/10.1016/S1521-6616(03)00064-0>10.1016/S1521-6616(03)00064-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Liu J, Li, H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;63:983&#8211;992.</td><td><a href=http://dx.doi.org/10.1124/mol.63.5.983>10.1124/mol.63.5.983</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Zurier RB, Rossetti RG, Burstein SH, Bidinger B. Suppression of human monocyte interleukin-1 beta production by ajulemic acid, a nonpsychoactive cannabinoid.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 2003;65:649&#8211;655.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(02)01604-0>10.1016/S0006-2952(02)01604-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Walker</span> <span style='background:#DDDDDD'>JM</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Owen</span> <span style='background:#DDDDDD'>K</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Petros</span> <span style='background:#DDDDDD'>P</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Huang</span> <span style='background:#DDDDDD'>SM</span></span></aug>. <span style='background:#FFD9B3'>Antiallodynic and analgesic actions of ajulemic acid reversed by a cannabinoid antagonist</span>. Paper presented at: Society of Neuroscientists; November 9, <span style='background:#66FF66'>2000</span>; <span style='background:#C0FFC0'>New Orleans, LA</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 2004;50:985&#8211;998.</td><td><a href=http://dx.doi.org/10.1002/art.20050>10.1002/art.20050</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Burstein SH, Zurier RB. Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 2004;50:4078&#8211;4080.</td><td><a href=http://dx.doi.org/10.1002/art.20805>10.1002/art.20805</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>